Home314130 • KOSDAQ
add
Genome&Company Inc
Previous close
₩7,880.00
Day range
₩7,210.00 - ₩8,120.00
Year range
₩2,180.00 - ₩10,180.00
Market cap
256.65B KRW
Avg Volume
644.44K
P/E ratio
-
Dividend yield
-
Primary exchange
KOSDAQ
Market news
MSN
6 minutes ago
Dow's 667-point drop led by losses for shares of Sherwin-Williams Co., Goldman Sachs
0.15%
2.26%
Financials
Income Statement
Revenue
Net income
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | 5.87B | -18.89% |
Operating expense | 10.18B | 6.52% |
Net income | 14.61B | 315.30% |
Net profit margin | 248.95 | 365.43% |
Earnings per share | — | — |
EBITDA | -6.05B | -68.30% |
Effective tax rate | -2.69% | — |
Balance Sheet
Total assets
Total liabilities
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 36.83B | -54.49% |
Total assets | 145.01B | -1.58% |
Total liabilities | 30.43B | -36.96% |
Total equity | 114.58B | — |
Shares outstanding | 32.17M | — |
Price to book | 2.51 | — |
Return on assets | -12.48% | — |
Return on capital | -13.69% | — |
Cash Flow
Net change in cash
| (KRW) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | 14.61B | 315.30% |
Cash from operations | -4.48B | 1.29% |
Cash from investing | -4.91B | -195.94% |
Cash from financing | -11.72B | -1,446.99% |
Net change in cash | -20.54B | -355.72% |
Free cash flow | -9.78B | -75.23% |
About
Founded
2015
Website
Employees
98
